Free Trial

Travis Steed Analyst Performance

Analyst at Bank of America

Travis Steed is a stock analyst at Bank of America focused in the medical sector, covering 14 publicly traded companies. Over the past year, Travis Steed has issued 9 stock ratings, including buy and hold recommendations. While full access to Travis Steed's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Travis Steed's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
22 Last 8 Years
Buy Recommendations
59.09% 13 Buy Ratings
Companies Covered
14 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy59.1%13 ratings
Hold40.9%9 ratings
Sell0.0%0 ratings

Out of 22 total stock ratings issued by Travis Steed at Bank of America, the majority (59.1%) have been Buy recommendations, followed by 40.9% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
7 companies
NASDAQ
50.0% of companies on NASDAQ
7 companies

Travis Steed, an analyst at Bank of America, currently covers 14 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
13 companies
92.9%
Manufacturing
1 company
7.1%

Travis Steed of Bank of America specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
7 companies
50.0%
MED PRODUCTS
3 companies
21.4%
MED/DENTAL - SUPP
2 companies
14.3%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
7.1%
MEDICAL SERVICES
1 company
7.1%

Travis Steed's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4/17/2026Lower Price Target$95.08$120.00Buy
MiniMed Group Inc stock logo
MMED
MiniMed Group
3/31/2026Initiated Coverage$14.35$27.00Buy
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2/20/2026Upgrade$18.52$30.00Neutral
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
1/9/2026Downgrade$31.99Neutral
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
1/5/2026Boost Price Target$29.25$33.00Buy
Penumbra, Inc. stock logo
PEN
Penumbra
1/5/2026Boost Price Target$309.44$370.00Buy
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
1/5/2026Boost Price Target$194.73$207.00Neutral
CONMED Corporation stock logo
CNMD
CONMED
12/8/2025Lower Price Target$40.16$52.00Neutral
Masimo Corporation stock logo
MASI
Masimo
11/17/2025Initiated Coverage$151.12$162.00Neutral
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4/7/2025Lower Price Target$205.77$261.00Overweight
Penumbra, Inc. stock logo
PEN
Penumbra
3/14/2025Initiated Coverage$260.75$320.00Buy
Abbott Laboratories stock logo
ABT
Abbott Laboratories
3/10/2025Boost Price Target$138.84$150.00Buy
Solventum Corporation stock logo
SOLV
Solventum
2/26/2025Boost Price Target$83.74$85.00Neutral
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2/14/2025Boost Price Target$224.98$279.00Overweight